Long-Term Liabilities: The sum of all non-current liabilities.
NLS Pharmaceutics Ltd. (NLSP) had Long-Term Liabilities of $2.74M for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$1.19M |
|
$0.00M |
|
$0.00M |
|
$1.19M |
|
$7.72M |
|
-- |
|
|
Long-Term Liabilities |
$2.74M |
$10.46M |
|
$-9.27M |
|
$-9.27M |
|
$-9.27M |
|
0.99M |
|
| Cash Flow Statement Financials | |
$-1.53M |
|
-- |
|
$1.19M |
|
$0.90M |
|
$0.55M |
|
$-0.34M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|